CARN-AP flashcards
CARN-AP · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- AUDIT-C positive thresholds
- AUDIT-C scores of 3 or more in women and 4 or more in men are positive, indicating hazardous drinking and need for further assessment.
- CAGE score meaning
- Two or more affirmative CAGE answers suggest a clinically significant alcohol problem; the tool is a screening aid and does not establish a diagnosis.
- DSM-5-TR SUD severity
- Two or three of eleven criteria indicate mild substance use disorder, four or five indicate moderate, and six or more indicate severe disorder within a twelve-month period.
- CIWA-Ar score interpretation
- CIWA-Ar scores of 8 to 15 indicate moderate alcohol withdrawal, while scores above 15 indicate severe withdrawal with increased risk of seizures and delirium.
- COWS score interpretation
- COWS scores of 13 to 24 indicate moderate opioid withdrawal, 25 to 36 moderately severe, and above 36 severe; buprenorphine induction often starts at 8 to 12.
- EtG detection window
- Urine ethyl glucuronide remains detectable for about 80 hours after alcohol is eliminated, indicating recent alcohol exposure rather than current intoxication or impairment.
- Naltrexone induction requirement
- Naltrexone requires seven to ten opioid-free days before starting; it is contraindicated during current opioid use and requires liver enzyme monitoring.
- Buprenorphine precipitated withdrawal
- Buprenorphine is a partial mu-opioid agonist; administering it while full agonists remain bound can abruptly precipitate withdrawal, so induction is timed to COWS scores of 8 to 12.
- Acamprosate dosing
- Acamprosate is typically dosed at 666 mg three times daily; the dose is reduced in moderate renal impairment and avoided in severe renal impairment.
- Disulfiram contraindications
- Disulfiram is contraindicated in severe myocardial disease, psychosis, pregnancy, and recent alcohol or disulfiram-like substance use; baseline liver tests are required.
- Thiamine before glucose
- In patients at risk for Wernicke encephalopathy, thiamine should be given before or with glucose because glucose administration can worsen thiamine deficiency.
- Naloxone repeat dosing
- Naloxone may be repeated every two to three minutes until respiratory drive returns; it can precipitate acute opioid withdrawal but is not harmful in opioid-naive patients.
- OARS in motivational interviewing
- OARS stands for open questions, affirmations, reflections, and summaries; these skills evoke change talk and strengthen the therapeutic alliance in motivational interviewing.
- Change talk versus sustain talk
- Change talk expresses desire, ability, reasons, or need for change, while sustain talk favors continued use; clinicians reflect change talk and avoid arguing with sustain talk.
- Contingency management
- Contingency management provides tangible reinforcers such as vouchers for verified abstinence; it has strong evidence for stimulant use disorders and improves treatment retention.
- CRAFT family intervention
- CRAFT teaches family members to reinforce abstinence and reduce enabling behaviors; it improves treatment engagement compared with confrontation-based family approaches.
- Relapse prevention high-risk situations
- Relapse prevention identifies high-risk situations, automatic thoughts, and coping responses; it treats a lapse as a learning event rather than a failure.
- 42 CFR Part 2 protection
- 42 CFR Part 2 protects substance use disorder treatment records more strictly than HIPAA; redisclosure generally requires written patient consent unless a specific exception applies.
- ASAM level 3.7
- ASAM level 3.7 is medically managed intensive inpatient treatment for severe withdrawal or medical instability requiring twenty-four-hour physician and nursing care.
- Warm handoff
- A warm handoff transfers care directly between clinicians with the patient present; it improves engagement and reduces dropout compared with fax-only or electronic referrals.
- MAT Act and X-waiver
- The MAT Act eliminated the X-waiver for buprenorphine; prescribers still need a DEA registration and must meet state licensure, training, and attestation requirements.
- SBIRT model
- SBIRT means screening, brief intervention, and referral to treatment; brief intervention suits risky use, while moderate-to-severe disorders require referral.
- Recovery capital
- Recovery capital is the sum of social, physical, human, and cultural resources that support sustained remission and is assessed during treatment and recovery planning.
- Syringe services programs
- Syringe services programs provide sterile injection equipment and reduce HIV and hepatitis C transmission without increasing injection frequency or crime.
- PrEP eligibility
- PrEP with tenofovir/emtricitabine reduces HIV acquisition; eligibility includes ongoing injection drug use with needle sharing or high-risk sexual behavior.
- HALT relapse framework
- HALT stands for hungry, angry, lonely, and tired; it is a self-monitoring framework for identifying vulnerability states that raise relapse risk.
- Peer recovery specialist role
- Peer recovery specialists use lived experience to support engagement, linkage, and recovery planning; they complement but do not replace licensed clinical assessment and treatment.
- Tarasoff duty
- The Tarasoff duty requires clinicians to warn or protect an identifiable third party when a patient poses a serious threat; the scope varies by state law.
- Mandated reporting
- Mandated reporting laws require clinicians to report suspected child abuse or neglect to the designated agency; the report is not made to the family.
- Informed consent elements
- Informed consent requires capacity, disclosure of risks and alternatives, voluntariness, and documentation; it is an ongoing process rather than a one-time signature.
- Dual relationship risk
- A dual relationship occurs when a clinician has a secondary role with a patient; it risks exploitation and impaired judgment and is generally avoided when possible.
- PDMP check purpose
- Prescription drug monitoring programs identify multiple prescribers, overlapping controlled substances, and high-risk combinations; checks are required or recommended before prescribing controlled substances.